- Home
- ELDN vs IHRT Comparison
ELDN vs IHRT Comparison
Compare ELDN & IHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- IHRT
- Stock Information
- Founded
- ELDN 2004
- IHRT 1974
- Country
- ELDN United States
- IHRT United States
- Employees
- ELDN N/A
- IHRT N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- IHRT Broadcasting
- Sector
- ELDN Health Care
- IHRT Consumer Discretionary
- Exchange
- ELDN Nasdaq
- IHRT Nasdaq
- Market Cap
- ELDN 178.4M
- IHRT 193.4M
- IPO Year
- ELDN N/A
- IHRT 2019
- Fundamental
- Price
- ELDN $2.72
- IHRT $1.83
- Analyst Decision
- ELDN Strong Buy
- IHRT Buy
- Analyst Count
- ELDN 2
- IHRT 3
- Target Price
- ELDN $12.50
- IHRT $2.92
- AVG Volume (30 Days)
- ELDN 198.6K
- IHRT 690.6K
- Earning Date
- ELDN 08-18-2025
- IHRT 08-07-2025
- Dividend Yield
- ELDN N/A
- IHRT N/A
- EPS Growth
- ELDN N/A
- IHRT N/A
- EPS
- ELDN N/A
- IHRT N/A
- Revenue
- ELDN N/A
- IHRT $3,862,595,000.00
- Revenue This Year
- ELDN N/A
- IHRT N/A
- Revenue Next Year
- ELDN N/A
- IHRT $5.89
- P/E Ratio
- ELDN N/A
- IHRT N/A
- Revenue Growth
- ELDN N/A
- IHRT 3.31
- 52 Week Low
- ELDN $2.30
- IHRT $0.95
- 52 Week High
- ELDN $5.54
- IHRT $2.84
- Technical
- Relative Strength Index (RSI)
- ELDN 35.43
- IHRT 67.99
- Support Level
- ELDN $2.76
- IHRT $1.58
- Resistance Level
- ELDN $2.90
- IHRT $1.83
- Average True Range (ATR)
- ELDN 0.16
- IHRT 0.14
- MACD
- ELDN -0.03
- IHRT 0.02
- Stochastic Oscillator
- ELDN 4.39
- IHRT 87.50
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About IHRT iHeartMedia Inc.
iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.